Peer-reviewedCC BYFrontiers in urology
5-α-reductase inhibitors and the risk of suicide and neuropsychiatric symptoms: a meta-analysis of observational studies
- 1Department of Experimental Medicine, University of Campania “Luigi Vanvitelli” , ,
- 2Coordination of the Regional Health System, General Directorate for Health Protection, Department of Experimental Medicine, University of Campania Luigi Vanvitelli , ,
Related
- Longitudinal associations between neuropsychiatric symptoms, structural and perfusion MRI changes in older adults with Mild Cognitive Impairment
- Therapeutic Reversal of Severe Neuropsychiatric Symptoms in Wilson's Disease: A Case Report.
- Longitudinal Changes in Structural and Functional Brain Imaging and Their Association with Cognitive and Neuropsychiatric Symptoms in Hashimoto Encephalopathy with Anti-NAE Antibody
- The relationship between 5α-reductase inhibitors and the presence of following open angle glaucoma: a TriNetX cohort study.
- The efficacy of NMDA receptor antagonists in neuropsychiatric and non-motor symptoms of Parkinson’s disease: a systematic review
BibTeX
@article{fraenza20265αreductase,
title = {{5-α-reductase inhibitors and the risk of suicide and neuropsychiatric symptoms: a meta-analysis of observational studies}},
author = {Federica Fraenza and Valerio Liguori and Ciro Pentella and Consiglia Riccardi and Francesca Futura Bernardi and Annalisa Capuano and Cristina Scavone},
journal = {Frontiers in urology},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13671994},
note = {CC BY},
}
RIS
TY - JOUR
TI - 5-α-reductase inhibitors and the risk of suicide and neuropsychiatric symptoms: a meta-analysis of observational studies
AU - Federica Fraenza
AU - Valerio Liguori
AU - Ciro Pentella
AU - Consiglia Riccardi
AU - Francesca Futura Bernardi
AU - Annalisa Capuano
AU - Cristina Scavone
PY - 2026
DA - 2026/10/19
JO - Frontiers in urology
UR - https://europepmc.org/article/PMC/PMC13671994
SN - 2673-9828
ER -